We are live on
!
Find out more
Ensign Peak Advisors Portfolio holdings
AUM
$53.7B
1-Year Est. Return
29.47%
This Fund
S&P 500
This Quarter
Est. Return
-3.67%
1 Year Est. Return
+29.47%
3 Year Est. Return
+102.45%
5 Year Est. Return
+139.11%
10 Year Est. Return
–
AUM
$40.3B
AUM Growth
-$1.82B
(-4.3%)
Cap. Flow
+$332M
Cap. Flow
% of AUM
0.83%
Top 10 Holdings %
Top 10 Hldgs %
25.24%
Holding
2,393
New
237
Increased
785
Reduced
642
Closed
83
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Mastercard
MA
|
+$231M |
| 2 |
Gilead Sciences
GILD
|
+$113M |
| 3 |
PG&E
PCG
|
+$102M |
| 4 |
iShares 1-3 Year Treasury Bond ETF
SHY
|
+$80.2M |
| 5 |
Allstate
ALL
|
+$64.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Visa
V
|
+$472M |
| 2 |
AbbVie
ABBV
|
+$121M |
| 3 |
iShares MSCI USA Value Factor ETF
VLUE
|
+$69.5M |
| 4 |
Salesforce
CRM
|
+$64.3M |
| 5 |
Home Depot
HD
|
+$62.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.24% |
| 2 | Healthcare | 19.03% |
| 3 | Financials | 13.02% |
| 4 | Consumer Discretionary | 9.39% |
| 5 | Industrials | 7.38% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
276
Phathom Pharmaceuticals
PHAT
$953M
| $19.5M | 0.05% |
1,761,191
+85,703
| +5% | +$817K |
|
277
Biogen
BIIB
$29.5B
| $19.4M | 0.05% |
72,742
+40,076
| +123% | +$8.51M |
|
278
iShares MSCI Saudi Arabia ETF
KSA
$623M
| $19.4M | 0.05% |
472,218
+4,664
| +1% | +$201K |
|
279
Globant
GLOB
$1.41B
| $19.3M | 0.05% |
103,309
+28,427
| +38% | +$5.86M |
|
280
US Bancorp
USB
$98.9B
| $19.2M | 0.05% |
475,966
+112,280
| +31% | +$5.2M |
|
281
Travelers Companies
TRV
$81.4B
| $19.1M | 0.05% |
124,456
+17,130
| +16% | +$2.78M |
|
282
APA Corp
APA
$12.3B
| $18.8M | 0.05% |
550,180
-14,125
| -3% | -$505K |
|
283
BioMarin Pharmaceuticals
BMRN
$11.6B
| $18.6M | 0.05% |
219,572
+129,246
| +143% | +$11.5M |
|
284
Fidelity National Financial
FNF
$14B
| $18.5M | 0.05% |
532,137
-131,388
| -20% | -$4.91M |
|
285
Palo Alto Networks
PANW
$259B
| $18.4M | 0.05% |
225,268
+52,870
| +31% | +$4.58M |
|
286
Littelfuse
LFUS
$10.2B
| $18.1M | 0.05% |
91,159
-7,853
| -8% | -$1.88M |
|
287
Prudential Financial
PRU
$42.3B
| $18.1M | 0.04% |
210,809
-61,810
| -23% | -$5.95M |
|
|
PXD
288
DELISTED
Pioneer Natural Resource Co.
PXD
| $18M | 0.04% |
83,267
-7,136
| -8% | -$1.63M |
|
289
IDEX
IEX
$16.6B
| $17.8M | 0.04% |
89,198
-899
| -1% | -$182K |
|
290
PACCAR
PCAR
$70.2B
| $17.2M | 0.04% |
308,754
+10,927
| +4% | +$635K |
|
291
MongoDB
MDB
$24.9B
| $17.1M | 0.04% |
85,956
+28,120
| +49% | +$8.21M |
|
292
Builders FirstSource
BLDR
$7.82B
| $17M | 0.04% |
287,995
+109,010
| +61% | +$6.82M |
|
293
Owens Corning
OC
$11.6B
| $16.9M | 0.04% |
214,825
-3,380
| -2% | -$284K |
|
294
Royal Caribbean
RCL
$81.8B
| $16.7M | 0.04% |
441,637
+32,642
| +8% | +$1.32M |
|
295
Cadence Design Systems
CDNS
$93.4B
| $16.7M | 0.04% |
101,901
-1,602
| -2% | -$275K |
|
296
Extra Space Storage
EXR
$31.3B
| $16.5M | 0.04% |
95,797
+16,585
| +21% | +$3.14M |
|
297
Quest Diagnostics
DGX
$25.6B
| $16.4M | 0.04% |
133,351
-11,320
| -8% | -$1.49M |
|
298
United Therapeutics
UTHR
$26.3B
| $15.9M | 0.04% |
76,057
+11,615
| +18% | +$2.6M |
|
299
McCormick & Company Non-Voting
MKC
$13.6B
| $15.9M | 0.04% |
222,738
-2,662
| -1% | -$223K |
|
300
Citizens Financial Group
CFG
$30.1B
| $15.7M | 0.04% |
456,067
-61,705
| -12% | -$2.28M |
|
Similar funds
SCP
Ensign Peak Advisors's Q3 2022 Portfolio in Review
As of Q3 2022, Ensign Peak Advisors held 2,393 positions worth $40.3B, down 4.3% from $42.1B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Ensign Peak Advisors's Q3 2022 filing shows 237 new, 785 increased, 642 reduced and 83 closed positions. Its largest new stake was iShares 1-3 Year Treasury Bond ETF: 975,000 shares worth $79.2M. The largest sale was Visa, an estimated $472M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 20% a quarter earlier, followed by Healthcare and Financials.
- Ensign Peak Advisors's largest Q3 2022 buy was iShares 1-3 Year Treasury Bond ETF: 975,000 shares worth $79.2M.
- Ensign Peak Advisors added most to Mastercard in Q3 2022, an estimated $231M increase.
- Ensign Peak Advisors's biggest Q3 2022 reduction was AbbVie, cutting an estimated $121M.
- Ensign Peak Advisors fully exited Visa in Q3 2022, selling an estimated $472M.
- Ensign Peak Advisors's ten largest holdings make up 25% of its $40.3B portfolio in Q3 2022.
- Ensign Peak Advisors opened 237 new positions and closed 83 in Q3 2022.
- Ensign Peak Advisors's portfolio value fell 4.3% quarter-over-quarter to $40.3B.
Based on Ensign Peak Advisors's 13F filing for Q3 2022, filed 14 Nov 2022.